Effect of fluvoxamine on plasma interleukin-6 in patients with major depressive disorder: a prospective follow-up study

INTRODUCTION: Major depressive disorder (MDD) is associated with low-grade inflammation, and anti-inflammatory treatment can help improve depressive symptoms. A recent study found that fluvoxamine (FLV) can reduce Interleukin-6 (IL-6) production via sigma-1 receptor in inflammation models. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xueqin, Yan, Danfeng, Liao, Mei, Zhang, Li, Li, ZeXuan, Liu, Bangshan, Chen, Yanjun, Zhang, Yan, Liu, Jin, Li, LingJiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247978/
https://www.ncbi.nlm.nih.gov/pubmed/37304432
http://dx.doi.org/10.3389/fpsyt.2023.1163754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247978/
https://www.ncbi.nlm.nih.gov/pubmed/37304432
http://dx.doi.org/10.3389/fpsyt.2023.1163754

Ejemplares similares